期刊文献+

腮腺腺样囊性癌中PTEN、MDM2表达 被引量:3

Adenoid Cystic Carcinoma of Parotid Gland Expression of PTEN and MDM2
原文传递
导出
摘要 目的:研究腮腺腺样囊性癌组织中抑癌基因PTEN、癌基因MDM2蛋白表达,探讨PTEN、MDM2在腮腺腺样囊性癌中两者之间的相关性,为将来临床应用提供参考。方法:选取腮腺腺样囊性癌手术存档石蜡标本30例,另取10例腮腺腺样囊性癌癌旁正常组织石蜡标本作为对照组,采用免疫组化SP法检验PTEN、MDM2表达情况。结果:腮腺腺样囊性癌和癌旁正常组织中PTEN蛋白的阳性率分别为20%(6/30)和70%(7/10),二者存在显著性差异(P<0.05)。MDM2蛋白在两种组织中阳性率分别为66%(20/30)和20%(2/10)(P<0.05),二者存在显著性差异(P<0.05)(r=-0.657),在腮腺腺样囊性癌中PTEN、MDM2的表达负相关。结论:PTEN、MDM2蛋白异常表达在腮腺腺样囊性癌的发生发展中起重要作用。 Objective: To study the expression of PTEN and MDM2 in the tissue of adenoid cystic carcinoma of parotid gland, investigate the correlation between PTEN and MDM2 to provide the reference for future clinical applications. Method: 30 cases of cancer tissues and 10 cases of noncancerous tissues were stained with PTEN and MDM2 by immunohistochemical method. Result: The positive rate of PTEN protein in cancerous tissue and normal tissue was 20% (6/30) and 70% (7/10), they exist significant difference (P〈 0.05). The positive rate of MDM2 protein in the two kinds of organizations was 66% (20/30) and 20% (2/10) (P〈0.05), they exist significant difference (P 〈0.05) (r = -0.657). The expression of PTEN and MDM2 in cancer tissues was negatively correlated. Conclusion: The expression of PTEN and MDM2 protein plays an important role in the occurrence and development with adenoid cystic carcinoma of parotid gland.
出处 《现代生物医学进展》 CAS 2014年第7期1300-1303,共4页 Progress in Modern Biomedicine
关键词 PTEN MDM2 腮腺 腺样囊性癌 免疫组化 PTEN MDM2 Parotid gland Adenoid cystic carcinoma Immunohistochemicing
  • 相关文献

参考文献2

二级参考文献20

  • 1沈丽佳,谢思明,殷操,阮萍,姚希.抑癌基因PTEN和FHIT在口腔鳞癌中的表达及其与cyclin D1的相关性[J].第一军医大学学报,2005,25(1):79-82. 被引量:14
  • 2杨志芳,易继林,李兴睿,谢大兴,廖晓锋.PTEN依赖其磷酸酶活性诱导肝癌细胞发生失巢凋亡机制的探讨[J].中华肿瘤杂志,2005,27(5):273-275. 被引量:10
  • 3Mayo LD, Dixon JE, Durden DL, et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Churn, 2002, 277:5484-5489.
  • 4Hunter T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell. 1995. 80:225-236.
  • 5Roux P. PTEN: a tumor suppressor with original properties. Bull Cancer, 1999,86: 522-525.
  • 6Rasheed BK, Stenzel qT, McLendon RE, et al. PTEN gene mutationssare seen in high-grade but not in low-grade gliomas. Cancer Res, 1997,57: 4187-4190.
  • 7Lin H, Bondy ML, Langford LA, et al. Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. Clin Cancer Res, 1998, 4: 2447-2454.
  • 8Stambolic V, Smarki A, de la Poma JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell,1998, 95:29-39.
  • 9Haas-Kogan D, Shalev N, Wong M, et al. Protein kinase B (PKB/Akt)activity is elevated in glioblastoma cells due to mutation of the tumor suppressor FFEN/MMAC. Curr Biol, 1998,8: 1195-1198.
  • 10Fakharzadeh SS, Rosenblum-Vos L, Murphy M, et al. Structure and organization of amplified DNA on double minutes containing the mdm2 oncogene. Genomics, 1993, 15: 283-290.

共引文献18

同被引文献33

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部